Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nebraska University seeks buyer for kidney marker:

This article was originally published in Clinica

Executive Summary

Research Corporation Technologies is seeking licensees for a kidney disease marker discovered at the University of Nebraska Medical Centre. The marker, called nephropathy-related protein, was found by Dr Thomas McDonald, who has undertaken research to show that it is present in pre-symptomatic patients as well as those suffering end-stage renal disease and transplant patients with early signs of rejection. Research Corporation Technologies holds both US and international rights and can be contacted in Tucson, Arizona on +1 (520) 748 4400.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT089822

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel